These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34873077)

  • 1. Immunotherapeutic approaches to HIV cure and remission.
    Lee MJ; Fidler S; Frater J
    Curr Opin Infect Dis; 2022 Feb; 35(1):31-41. PubMed ID: 34873077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilizing immunotherapy towards achieving a functional cure for HIV-1.
    Sugiyama FHC; Dietz LL; Søgaard OS
    Curr Opin HIV AIDS; 2024 Jul; 19(4):187-193. PubMed ID: 38686856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure.
    Maina EK; Adan AA; Mureithi H; Muriuki J; Lwembe RM
    Curr HIV Res; 2021; 19(1):14-26. PubMed ID: 32819259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological approaches to HIV cure.
    Ward AR; Mota TM; Jones RB
    Semin Immunol; 2021 Jan; 51():101412. PubMed ID: 32981836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Pediatric HIV-1 Cure Therapies and Reservoir Assays.
    Khetan P; Liu Y; Dhummakupt A; Persaud D
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials aimed at HIV cure or remission: new pathways and lessons learned.
    Schou MD; Søgaard OS; Rasmussen TA
    Expert Rev Anti Infect Ther; 2023; 21(11):1227-1243. PubMed ID: 37856845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies.
    Delannoy A; Poirier M; Bell B
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30889861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing natural killer cells to target HIV-1 persistence.
    Joshi VR; Altfeld M
    Curr Opin HIV AIDS; 2024 May; 19(3):141-149. PubMed ID: 38457230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring the Success of HIV-1 Cure Strategies.
    Thomas J; Ruggiero A; Paxton WA; Pollakis G
    Front Cell Infect Microbiol; 2020; 10():134. PubMed ID: 32318356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of latency reversal in HIV cure strategies.
    Tanaka K; Kim Y; Roche M; Lewin SR
    J Med Primatol; 2022 Oct; 51(5):278-283. PubMed ID: 36029233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the HIV-1 Latent Reservoir and Strategies to Cure HIV-1 Infection.
    Bai R; Lv S; Wu H; Dai L
    Dis Markers; 2022; 2022():6952286. PubMed ID: 35664434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
    Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
    mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Immunodeficiency Virus 1 (HIV-1): Viral Latency, the Reservoir, and the Cure.
    Ventura JD
    Yale J Biol Med; 2020 Sep; 93(4):549-560. PubMed ID: 33005119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boosting the Immune System for HIV Cure: A γδ T Cell Perspective.
    Mann BT; Sambrano E; Maggirwar SB; Soriano-Sarabia N
    Front Cell Infect Microbiol; 2020; 10():221. PubMed ID: 32509594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing proviral competence: current approaches to evaluate HIV-1 persistence.
    Cicilionytė A; Berkhout B; Pasternak AO
    Curr Opin HIV AIDS; 2021 Jul; 16(4):223-231. PubMed ID: 33993171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Dendritic Cells in Exposing Latent HIV-1 for the Kill.
    Kristoff J; Rinaldo CR; Mailliard RB
    Viruses; 2019 Dec; 12(1):. PubMed ID: 31905690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Interventions in HIV Cure Research.
    Rasmussen TA; Søgaard OS
    Adv Exp Med Biol; 2018; 1075():285-318. PubMed ID: 30030798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1.
    Kristoff J; Palma ML; Garcia-Bates TM; Shen C; Sluis-Cremer N; Gupta P; Rinaldo CR; Mailliard RB
    EBioMedicine; 2019 May; 43():295-306. PubMed ID: 30952614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifarious immunotherapeutic approaches to cure HIV-1 infection.
    Imami N; Herasimtschuk AA
    Hum Vaccin Immunother; 2015; 11(9):2287-93. PubMed ID: 26048144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.